Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing important new therapies for the treatment ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and therapies for other ophthalmic ...

The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...

Pancreatic cancer, one of the deadliest types of the disease, has been linked to obesity and higher stress levels, a new UCLA ...

Only phenylephrine itself is active as an alpha-1 adrenergic receptor agonist that can tackle the dilation of nasal blood vessels that is a major feature of nasal congestion; its metabolites are not.

Phenylephrine itself is active as an alpha-1 adrenergic receptor agonist that can tackle the dilation of nasal blood vessels, which is a major feature of nasal congestion. However, its metabolites ...

Guanfacine belongs to the class of medications known as central alpha 2A-adrenergic receptor agonists ... For Intuniv, your child can often be given a 1-milligram (mg) dose once daily.

It acts through agonist effects on the alpha-2 adrenergic system at both the spinal and supraspinal levels to reduce spasm. Peak plasma levels occur 1 hour after oral administration, with a half ...

Adrenergic receptors and cardiovascular effects of catecholamines ... Norepinephrine Has Dual Effects on Human Colonic Contractions Through Distinct Subtypes of Alpha 1 Adrenoceptors. Cell Mol ...